|
1
|
Kilcline C and Frieden IJ: Infantile
hemangiomas: How common are they? A systematic review of the
medical literature. Pediatr Dermatol. 25:168–173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takahashi K, Mulliken JB, Kozakewich HP,
Rogers RA, Folkman J and Ezekowitz RA: Cellular markers that
distinguish the phases of hemangioma during infancy and childhood.
J Clin Invest. 93:2357–2364. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mulliken JB and Young AE: Vascular
birthmarks: Hemangiomas and malformations. W. B. Saunders Co.;
Philadelphia: 1988
|
|
4
|
Risau W and Flamme I: Vasculogenesis. Annu
Rev Cell Dev Biol. 11:73–91. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Flamme I, Frölich T and Risau W: Molecular
mechanisms of vasculogenesis and embryonic angiogenesis. J Cell
Physiol. 173:206–210. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carmeliet P: Angiogenesis in health and
disease. Nat Med. 9:653–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brandling-Bennett HA, Metry DW, Baselga E,
Lucky AW, Adams DM, Cordisco MR and Frieden IJ: Infantile
hemangiomas with unusually prolonged growth phase: A case series.
Arch Dermatol. 144:1632–1637. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stiles J, Amaya C, Pham R, Rowntree RK,
Lacaze M, Mulne A, Bischoff J, Kokta V, Boucheron LE, Mitchell DC
and Bryan BA: Propranolol treatment of infantile hemangioma
endothelial cells: A molecular analysis. Exp Ther Med. 4:594–604.
2012.PubMed/NCBI
|
|
11
|
Bourdelat D, Melki E, Mazzola C and
Marreel A: Congenital prenatal hemangioma: Diagnosis and treatment.
Arch Pediatr. 17:383–386. 2010.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan WL, Qin XJ and Wang XK: Expression
and correlation of mast cell, Clusterin/apoJ and transforming
growth factor-beta in the different stages of human dermal
hemangioma. Hua Xi Kou Qiang Yi Xue Za Zhi. 27:361–365. 2009.(In
Chinese). PubMed/NCBI
|
|
13
|
Chang J, Most D, Bresnick S, Mehrara B,
Steinbrech DS, Reinisch J, Longaker MT and Turk AE: Proliferative
hemangiomas: Analysis of cytokine gene expression and angiogenesis.
Plast Reconstr Surg. 103:1–10. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan ST, Wallis RA, He Y and Davis PF: Mast
cells and hemangioma. Plast Reconstr Surg. 113:999–1011. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shan S, Shan G and Zhang D: Treatment of
hemangioma by transfection of antisense VEGF gene. J Huazhong Univ
Sci Technolog Med Sci. 29:335–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shan G, Tang T and Zhang D: Expression of
HLA-G in hemangioma and its clinical significance. J Huazhong Univ
Sci Technolog Med Sci. 32:713–718. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Razon MJ, Kräling BM, Mulliken JB and
Bischoff J: Increased apoptosis coincides with onset of involution
in infantile hemangioma. Microcirculation. 5:189–195. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cook BD, Ferrari G, Pintucci G and
Mignatti P: TGF-beta1 induces rearrangement of
FLK-1-VE-cadherin-beta-catenin complex at the adherens junction
through VEGF-mediated signaling. J Cell Biochem. 105:1367–1373.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sharma MR, Tuszynski GP and Sharma MC:
Angiostatin-induced inhibition of endothelial cell
proliferation/apoptosis is associated with the down-regulation of
cell cycle regulatory protein cdk5. J Cell Biochem. 91:398–409.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tobiume K: Involvement of Bcl-2 family
proteins in p53-induced apoptosis. J Nippon Med Sch. 72:192–193.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vaseva AV and Moll UM: The mitochondrial
p53 pathway. Biochim Biophys Acta. 1787:414–420. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Crowe DL and Sinha UK: P53 apoptotic
response to DNA damage dependent on bcl2 but not bax in head and
neck squamous cell carcinoma lines. Head Neck. 28:15–23. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hainaut P: The tumor suppressor protein
p53: A receptor to genotoxic stress that controls cell growth and
survival. Curr Opin Oncol. 7:76–82. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han Z, Chatterjee D, He DM, Early J,
Pantazis P, Wyche JH and Hendrickson EA: Evidence for a G2
checkpoint in p53-independent apoptosis induction by X-irradiation.
Mol Cell Biol. 15:5849–5857. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marinaş MC, Mogoş DG, Simionescu CE,
Stepan A and Tănase F: The study of p53 and p16 immunoexpression in
serous borderline and malignant ovarian tumors. Rom J Morphol
Embryol. 53:1021–1025. 2012.PubMed/NCBI
|
|
27
|
Cheok CF and Lane DP: Seeking synergy in
p53 transcriptional activation for cancer therapy. Discov Med.
14:263–271. 2012.PubMed/NCBI
|
|
28
|
Jayaraman B, Valiathan GM, Jayakumar K,
Palaniyandi A, Thenumgal SJ and Ramanathan A: Lack of mutation in
p53 and H-ras genes in phenytoin induced gingival overgrowth
suggests its non cancerous nature. Asian Pac J Cancer Prev.
13:5535–5538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martina JD, Simmons C and Jukic DM:
High-definition hematoxylin and eosin staining in a transition to
digital pathology. J Pathol Inform. 2:452011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mulliken JB and Glowacki J: Hemangiomas
and vascular malformations in infants and children: A
classification based on endothelial characteristics. Plast Reconstr
Surg. 69:412–422. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tomek M, Akiyama T and Dass CR: Role of
Bcl-2 in tumour cell survival and implications for pharmacotherapy.
J Pharm Pharmacol. 64:1695–1702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao Z, Shan J, Li C, Luo L, Lu J, Li S,
Long D and Li Y: Mechanisms of cyclosporine-induced renal cell
apoptosis: A systematic review. Am J Nephrol. 37:30–40. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sermeus A, Genin M, Maincent A, Fransolet
M, Notte A, Leclere L, Riquier H, Arnould T and Michiels C:
Hypoxia-induced modulation of apoptosis and BCL-2 family proteins
in different cancer cell types. PLoS One. 7:e475192012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shu R, Liu DL and Wang Q: Effect of
remifentanil on expression of Bcl-2 and caspase-3 in ratscerebral
cortex following Ischemia-reperfusion injury. Acta Medicinae
Universitatis Scientiae et Technologiae Huazhong. 41:72–75.
2012.(In Chinese).
|
|
35
|
Tsujimoto Y, Finger LR, Yunis J, Nowell PC
and Croce CM: Cloning of the chromosome breakpoint of neoplastic B
cells with the t(14;18) chromosome translocation. Science.
226:1097–1099. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McDonnell TJ, Deane N, Platt FM, Nunez G,
Jaeger U, McKearn JP and Korsmeyer SJ: bcl-2-immunoglobulin
transgenic mice demonstrate extended B cell survival and follicular
lymphoproliferation. Cell. 57:79–88. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Turner HE, Nagy Z, Gatter KC, Esiri MM,
Wass JA and Harris AL: Proliferation, bcl-2 expression and
angiogenesis in pituitary adenomas: Relationship to tumour
behaviour. Br J Cancer. 82:1441–1445. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gazzaniga P, Gandini O, Gradilone A,
Silvestri I, Giuliani L, Magnanti M, Gallucci M, Saccani G, Frati L
and Agliano AM: Detection of basic fibroblast growth factor mRNA in
urinary bladder cancer: Correlation with local relapses. Int J
Oncol. 14:1123–1127. 1999.PubMed/NCBI
|
|
39
|
Bielenberg DR, Bucana CD, Sanchez R,
Mulliken JB, Folkman J and Fidler IJ: Progressive growth of
infantile cutaneous hemangiomas is directly correlated with
hyperplasia and angiogenesis of adjacent epidermis and inversely
correlated with expression of the endogenous angiogenesis
inhibitor, IFN-beta. Int J Oncol. 14:401–408. 1999.PubMed/NCBI
|
|
40
|
Halasi M, Pandit B and Gartel AL:
Proteasome inhibitors suppress the protein expression of mutant
p53. Cell Cycle. 13:3202–3206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Giurgea LN, Ungureanu C and Mihailovici
MS: The immunohistochemical expression of p53 and Ki67 in ovarian
epithelial borderline tumors. Correlation with clinicopathological
factors. Rom J Morphol Embryol. 53:967–973. 2012.PubMed/NCBI
|
|
42
|
Rao Z and Ding Y: Ubiquitin pathway and
ovarian cancer. Curr Oncol. 19:324–328. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ji Y, Li K, Xiao X, Zheng S, Xu T and Chen
S: Effects of propranolol on the proliferation and apoptosis of
hemangioma-derived endothelial cells. J Pediatr Surg. 47:2216–2223.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Porter PL, Gown AM, Kramp SG and Coltrera
MD: Widespread p53 overexpression in human malignant tumors. An
immunohistochemical study using methacarn-fixed, embedded tissue.
Am J Pathol. 140:145–153. 1992.PubMed/NCBI
|
|
45
|
Itahana Y and Itahana K: Emerging roles of
mitochondrial p53 and ARF. Curr Drug Targets. 13:1633–1640. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Crasta JA, Mishra S and Vallikad E:
Ovarian serous carcinoma: Relationship of p53 and bcl-2 with tumor
angiogenesis and VEGF expression. Int J Gynecol Pathol. 30:521–526.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kang SM, Maeda K, Onoda N, Chung YS,
Nakata B, Nishiguchi Y and Sowa M: Combined analysis of p53 and
vascular endothelial growth factor expression in colorectal
carcinoma for determination of tumor vascularity and liver
metastasis. Int J Cancer. 74:502–507. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Koide N, Nishio A, Hiraguri M, Hanazaki K,
Adachi W and Amano J: Coexpression of vascular endothelial growth
factor and p53 protein in squamous cell carcinoma of the esophagus.
Am J Gastroenterol. 96:1733–1740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tian Y, Ding RY, Zhi YH, Guo RX and Wu SD:
Analysis of p53 and vascular endothelial growth factor expression
in human gallbladder carcinoma for the determination of tumor
vascularity. World J Gastroenterol. 12:415–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
